Search research articles
Contact Us
Filters
Showing results (21-30 of 278) with videos related to
Page
of 28
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
March 8, 2019
Distribution of main Gram-positive pathogens causing bloodstream infections in United States and European hospitals during the SENTRY Antimicrobial Surveillance Program (2010-2016): concomitant analysis of oritavancin in vitro activity
Rodrigo E Mendes, Helio S Sader, Mariana Castanheira, et al.
Antimicrobial Agents and Chemotherapy
|
January 13, 2025
Ceftobiprole activity against multidrug-resistant <i>Staphylococcus aureus</i> clinical isolates collected in the United States from 2016 through 2022
Helio S Sader, Jennifer I Smart, Rodrigo E Mendes, et al.
Antibiotics (Basel, Switzerland)
|
April 27, 2026
In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against <i>Streptococcus pneumoniae</i> Responsible for Lower Respiratory Tract Infections in the United States (2016-2020), Including Resistant Subsets and Select Serotypes
Helio S Sader, Mariana Castanheira, Mark E Jones, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2020
Activity of Plazomicin Tested against <i>Enterobacterales</i> Isolates Collected from U.S. Hospitals in 2016-2017: Effect of Different Breakpoint Criteria on Susceptibility Rates among Aminoglycosides
Mariana Castanheira, Helio S Sader, Rodrigo E Mendes, et al.
Medicine
|
September 12, 2009
Resurgence of Pseudomonas endocarditis in Detroit, 2006-2008
Milagros P Reyes, Ammar Ali, Rodrigo E Mendes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 7, 2011
In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States
Ronald N Jones, Rodrigo E Mendes, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
October 24, 2022
Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018-2020)
Helio S Sader, Mariana Castanheira, Leonard R Duncan, et al.
Journal of Clinical Microbiology
|
April 26, 2013
Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae testing susceptible to cefepime by reference methods
Renata C Picão, Ronald N Jones, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease
|
September 28, 2022
Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA, Europe, Latin America, and the Asia-Pacific region (2015-2019)
Michael Pfaller, Rodrigo E Mendes, Jennifer M Streit, et al.
The Journal of Antimicrobial Chemotherapy
|
March 23, 2011
Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09)
Mariana Castanheira, Rodrigo E Mendes, Leah N Woosley, et al.
Page
of 28
Search research articles
Search
Showing results (21-30 of 278) with videos related to
Sort By:
Page
of 28
Journal of Chemotherapy (Florence, Italy)
|
March 8, 2019
Distribution of main Gram-positive pathogens causing bloodstream infections in United States and European hospitals during the SENTRY Antimicrobial Surveillance Program (2010-2016): concomitant analysis of oritavancin in vitro activity
Rodrigo E Mendes, Helio S Sader, Mariana Castanheira, et al.
Antimicrobial Agents and Chemotherapy
|
January 13, 2025
Ceftobiprole activity against multidrug-resistant <i>Staphylococcus aureus</i> clinical isolates collected in the United States from 2016 through 2022
Helio S Sader, Jennifer I Smart, Rodrigo E Mendes, et al.
Antibiotics (Basel, Switzerland)
|
April 27, 2026
In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against <i>Streptococcus pneumoniae</i> Responsible for Lower Respiratory Tract Infections in the United States (2016-2020), Including Resistant Subsets and Select Serotypes
Helio S Sader, Mariana Castanheira, Mark E Jones, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2020
Activity of Plazomicin Tested against <i>Enterobacterales</i> Isolates Collected from U.S. Hospitals in 2016-2017: Effect of Different Breakpoint Criteria on Susceptibility Rates among Aminoglycosides
Mariana Castanheira, Helio S Sader, Rodrigo E Mendes, et al.
Medicine
|
September 12, 2009
Resurgence of Pseudomonas endocarditis in Detroit, 2006-2008
Milagros P Reyes, Ammar Ali, Rodrigo E Mendes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 7, 2011
In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States
Ronald N Jones, Rodrigo E Mendes, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
October 24, 2022
Update on the in vitro activity of ceftaroline against Staphylococcus aureus from United States (US) medical centers stratified by infection type (2018-2020)
Helio S Sader, Mariana Castanheira, Leonard R Duncan, et al.
Journal of Clinical Microbiology
|
April 26, 2013
Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae testing susceptible to cefepime by reference methods
Renata C Picão, Ronald N Jones, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease
|
September 28, 2022
Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA, Europe, Latin America, and the Asia-Pacific region (2015-2019)
Michael Pfaller, Rodrigo E Mendes, Jennifer M Streit, et al.
The Journal of Antimicrobial Chemotherapy
|
March 23, 2011
Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09)
Mariana Castanheira, Rodrigo E Mendes, Leah N Woosley, et al.
Page
of 28